Axess'e özel, Onur Market'te 100 TL chip-para
Juzdan'dan kampanyaya katıl,
Onur Market mağazalarında tek seferde 1.000 TL ve üzeri ilk alışverişinde chip-para kazan.
Son gün: 31 Mart 2026
#OnurMarket #FazlasıOnurda #Akbank #Axess #Juzdan #Kampanya #ChipPara

Axess'e özel, Onur Market'te 100 TL chip-para
Juzdan'dan kampanyaya katıl,
Onur Market mağazalarında tek seferde 1.000 TL ve üzeri ilk alışverişinde chip-para kazan.
Son gün: 31 Mart 2026
#OnurMarket #FazlasıOnurda #Akbank #Axess #Juzdan #Kampanya #ChipPara

Axess'e özel, Onur Market'te 100 TL chip-para
Juzdan'dan kampanyaya katıl,
Onur Market mağazalarında tek seferde 1.000 TL ve üzeri ilk alışverişinde chip-para kazan.
Son gün: 31 Mart 2026
#OnurMarket #FazlasıOnurda #Akbank #Axess #Juzdan #Kampanya #ChipPara

Axess'e özel, Onur Market'te 100 TL chip-para
Juzdan'dan kampanyaya katıl,
Onur Market mağazalarında tek seferde 1.000 TL ve üzeri ilk alışverişinde chip-para kazan.
Son gün: 31 Ocak 2026
#OnurMarket #FazlasıOnurda #Akbank #Axess #Juzdan #Kampanya #ChipPara

Axess'e özel, Onur Market'te 100 TL chip-para
Juzdan'dan kampanyaya katıl,
Onur Market mağazalarında tek seferde 1.000 TL ve üzeri ilk alışverişinde chip-para kazan.
Son gün: 31 Ocak 2026
#OnurMarket #FazlasıOnurda #Akbank #Axess #Juzdan #Kampanya #ChipPara

Xeltis Receives €50 Million to Propel aXess Vascular Conduit Development Xeltis has secured almost €50 million from the European Investment Bank and existing shareholders to enhance its aXess vascular conduit. This investment supports its commercialization and further innovations in medical technology.

Xeltis Receives €50 Million to Propel aXess Vascular Conduit Development #EIB #Netherlands #Xeltis #aXess #Eindhoven

Flyttet til Molde alene: – Ble bedre enn forventet Du kan egentlig ha det bra omtrent hvor som helst, mener Anne Bondal. Så lenge du ikke forventer at alt lander i fanget på deg.

Les syndicats du privé non lucratif refusent une prime en guise de revalorisation L'accord de méthode validé en juin dernier dans la branche sanitaire, sociale et médico-sociale privée à but non lucratif n'est pas respecté. Organisations syndicales et employeurs s'opposent. Des pro...

Les organisations syndicales estiment que les salariés de la branche sanitaire, sociale et médico-sociale privée à but non lucratif méritent plus qu'une prime ponctuelle. Elles retrouveront #Axess en commission mixte paritaire le 4 novembre.

✍ @watlyd.bsky.social

@cfdt-sante-sociaux.bsky.social

Xeltis Launches Groundbreaking Vascular Access Technology for Hemodialysis Treatment Xeltis has released positive results from the pivotal aXess EU trial, showcasing a revolutionary solution for vascular access in hemodialysis treatment, paving the way for commercialization.

Xeltis Launches Groundbreaking Vascular Access Technology for Hemodialysis Treatment #Xeltis #aXess #Eindhoven #The_Netherlands #Hemodialysis

Manifestation du 15 mai 2024, Orne.

#Coallia #Orne #Normandie
#Axess #Nexem #Fehap
Non à la destruction des garanties collectives, aux déqualifications, à la dégradation des conditions de travail et à la désertion des métiers !

Xeltis Secures €10 Million Investment to Transform Vascular Surgery with Groundbreaking Technology Xeltis has passed the evaluation phase for a €10 million investment from the European Innovation Council to enhance its bioresorbable vascular conduits.

Xeltis Secures €10 Million Investment to Transform Vascular Surgery with Groundbreaking Technology #Netherlands #Xeltis #aXess #Eindhoven #EIC

Xeltis Enhances Medical Advisory Board with Renowned Nephrology Experts Xeltis announces the addition of Dr. An De Vriese and Dr. Monnie Wasse to its Medical Advisory Board, enhancing its clinical expertise in nephrology.

Xeltis Enhances Medical Advisory Board with Renowned Nephrology Experts #Netherlands #Xeltis #aXess #Eindhoven #Nephrology

Xeltis Completes Enrolment for aXess Trial and Readies for Market Entry Xeltis has completed patient enrolment for its aXess trial, aiming for a market approval soon. This marks a significant step in transforming vascular access for dialysis patients.

Xeltis Completes Enrolment for aXess Trial and Readies for Market Entry #Netherlands #medical_technology #Xeltis #aXess #Eindhoven

Har varit prenumerant till #Axess magasin för flera år. Porto till Finland (335 SEK) utgör nu 1/2 av hela avgiften. Dags att sluta, kanske.